查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1666715

嬰兒配方奶粉 DHA 藻油市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Infant Formula DHA Algae Oil Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 235 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球嬰兒配方奶粉 DHA 藻類油市場價值為 3.672 億美元，預計 2025 年至 2034 年的複合年成長率將達到 7%。隨著消費者越來越重視更健康的飲食選擇，富含 DHA 的產品（如嬰兒配方奶粉、膳食補充劑和功能性食品）正迅速受到歡迎。父母尤其熱衷於確保孩子的大腦和視力得到最佳發育，這導致對富含 DHA 的產品的需求激增。此外，植物性 DHA 來源（尤其是藻類油）的日益普及進一步激發了消費者的興趣，因為這符合永續性和環保意識日益增強的趨勢。對植物性 DHA 的偏好，加上油萃取技術的進步，確保了市場持續擴張。

嬰兒配方奶粉 DHA 藻油市場 - IMG1

DHA 藻類油市場根據 DHA 濃度分為兩個主要類別：30%-40% 和 40%-50%。 40%-50% 濃度細分市場規模最大，2024 年市場價值為 1.225 億美元。這種需求源於人們越來越認知到 DHA 在認知、視覺和免疫系統健康方面的重要作用，尤其是在兒童發展的早期階段。父母比以往任何時候都更了解情況，可以做出有意識的決定，為孩子提供盡可能最有效的營養支持。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 3.672億美元
預測值 7.348 億美元
複合年成長率 7%

市場區隔還包括0-3歲、3-6歲等年齡層，以及其他組別，包括早產兒和大齡兒童。 0-3 年期市場佔據主導地位，到 2024 年佔有率將達到 96.9%，並且繼續保持最快的成長速度。嬰幼兒有特殊的營養需求，這對於大腦發育、視力健康和免疫系統增強至關重要。富含 DHA 的配方奶粉在滿足這些需求方面發揮著不可或缺的作用，並且隨著對這些益處的認知不斷提高，對注入 DHA 的嬰兒配方奶粉的需求將會飆升。

在美國，2024 年嬰兒配方奶粉中 DHA 藻油的市場規模將達到 2,230 萬美元。此外，家長們對 DHA 在兒童早期發展中的重要性的認知不斷加深，這也導致優質配方奶粉的採用率不斷提高。高可支配收入水平，加上電子商務等完善的分銷管道，使得美國消費者更容易買到這些產品。

目錄

第 1 章：方法論與範圍

  • 市場範圍和定義
  • 基礎估算與計算
  • 預測計算
  • 資料來源
    • 基本的
    • 次要
      • 付費來源
      • 公共資源

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
    • 影響價值鏈的因素
    • 利潤率分析
    • 中斷
    • 未來展望
    • 製造商
    • 經銷商
  • 供應商概況
  • 利潤率分析
  • 重要新聞及舉措
  • 監管格局
  • 衝擊力
    • 成長動力
      • 母乳替代需求不斷成長
      • 有利的監管前景
      • 嬰兒食品業大幅擴張
    • 產業陷阱與挑戰
      • 原物料價格波動
      • DHA 對嬰兒有益的科學證據相互矛盾
  • 成長潛力分析
  • 波特的分析
  • PESTEL 分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按內容，2021 年至 2034 年

  • 主要趨勢
  • 30% - 40%
  • 40% - 50%

第 6 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 0 – 3 歲
  • 3 – 6 歲
  • 其他（早產兒，7歲以上）

第 7 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東及非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章：公司簡介

  • Algarithm
  • Cellana
  • Far East Microalgae
  • Goerlich Pharma
  • Guangdong Runke Bio-Engineering
  • Henry Lamotte OILS
  • Hubei Fuxing Biotechnology
  • JC Biotech
  • Kingdomway Nutrition
  • Lonza
  • Meteoric Biopharmaceutical
  • Nordic Naturals
  • Polaris
  • Qingdao Keyuan Marine Biochemistry
  • Xiamen Huison Biotech
簡介目錄
Product Code: 4832

The Global Infant Formula DHA Algae Oil Market was valued at USD 367.2 million in 2024, with projections indicating a robust CAGR of 7% from 2025 to 2034. This growth can be largely attributed to a growing awareness of the numerous health benefits associated with DHA, a crucial omega-3 fatty acid. As consumers continue to prioritize healthier dietary choices, products enriched with DHA, such as infant formulas, dietary supplements, and functional foods, are rapidly gaining popularity. Parents are particularly keen on ensuring optimal brain and vision development for their children, leading to a surge in demand for DHA-enriched products. Furthermore, the increasing availability of plant-based DHA sources, particularly algae oil, has further driven consumer interest, as it aligns with the growing trend of sustainability and environmental consciousness. This preference for plant-based DHA, alongside advancements in oil extraction technology, ensures the market's continued expansion.

Infant Formula DHA Algae Oil Market - IMG1

The DHA algae oil market is segmented by DHA concentration into two primary categories: 30%-40% and 40%-50%. The 40%-50% concentration segment is the largest, generating USD 122.5 million in 2024. It is also the fastest-growing segment, with an increasing number of parents opting for formulas with higher DHA content. This demand is driven by a stronger recognition of DHA's vital role in cognitive, visual, and immune system health, particularly during the early stages of a child's development. Parents are more informed than ever, making conscious decisions to provide their children with the most effective nutritional support possible.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$367.2 Million
Forecast Value$734.8 Million
CAGR7%

Market segmentation also includes age groups such as 0-3 years, 3-6 years, and other groups, which include premature infants and older children. The 0-3 years segment dominated the market with a share of 96.9% in 2024, and it continues to see the fastest growth. Infants and toddlers have specific nutritional needs that are crucial for brain development, visual health, and immune system strengthening. DHA-enriched formulas play an integral role in meeting these needs, and as awareness of these benefits increases, the demand for DHA-infused infant formulas is set to soar.

In the U.S., the market for DHA algae oil in infant formulas accounted for USD 22.3 million in 2024. This growth is supported by regulatory frameworks, such as recommendations from the FDA and WHO, which require the inclusion of DHA in infant formulas. Additionally, parents' growing understanding of DHA's importance in early childhood development has led to increased adoption of premium formulas. High disposable income levels, coupled with well-established distribution channels, including e-commerce, have made these products more accessible to American consumers.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Growing demand for breast milk substitutes
      • 3.6.1.2 Favorable regulatory outlook
      • 3.6.1.3 Significant expansion of the baby food industry
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Price volatility of raw material
      • 3.6.2.2 Contradictory scientific evidence of DHA benefits in infants
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Content, 2021-2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 30% - 40%
  • 5.3 40% - 50%

Chapter 6 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 0 – 3 years old
  • 6.3 3 – 6 years old
  • 6.4 Others (premature infants, 7+ years old)

Chapter 7 Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 UK
    • 7.3.2 Germany
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Algarithm
  • 8.2 Cellana
  • 8.3 Far East Microalgae
  • 8.4 Goerlich Pharma
  • 8.5 Guangdong Runke Bio-Engineering
  • 8.6 Henry Lamotte OILS
  • 8.7 Hubei Fuxing Biotechnology
  • 8.8 JC Biotech
  • 8.9 Kingdomway Nutrition
  • 8.10 Lonza
  • 8.11 Meteoric Biopharmaceutical
  • 8.12 Nordic Naturals
  • 8.13 Polaris
  • 8.14 Qingdao Keyuan Marine Biochemistry
  • 8.15 Xiamen Huison Biotech